-
IntroducedFeb 06, 2026
-
Passed SenateMar 05, 2026
-
Passed House
-
Became Law
Kansas Senate Bill
Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition of fentanyl-related controlled substance in the criminal code.
Last Action See all actions
House • Mar 11, 2026: Hearing: Wednesday, March 11, 2026, 1:30 PM Room 112-N - CANCELED
Latest Bill Text See all bill texts
Summary
Comments on SB 497
Tweets
Whip Lists
Sponsors
- Committee on Public Health and Welfaresponsor

Votes
NO: 32
ABSENT: 1
NO: 30
ABSENT: 1
Actions
- Mar 11, 2026 | House
- Hearing: Wednesday, March 11, 2026, 1:30 PM Room 112-N - CANCELED
- Mar 06, 2026 | House
- Received and Introduced
- Referred to Committee on Health and Human Services
- Mar 05, 2026 | Senate
- Final Action - Passed; Yea: 33 Nay: 5
- Mar 04, 2026 | Senate
- Committee of the Whole - Motion to Amend - Offered by Senator Miller
- Committee of the Whole - Amendment by Senator Miller was rejected Yea: 7 Nay: 32
- Committee of the Whole - Motion to Amend - Offered by Senator Holscher
- Committee of the Whole - Amendment by Senator Holscher was rejected Yea: 9 Nay: 30
- Committee of the Whole - Be passed
- Feb 25, 2026 | Senate
- Withdrawn from Committee on Public Health and Welfare and referred to Committee of the Whole
- Feb 24, 2026 | Senate
- Withdrawn from Committee on Ways and Means; Rereferred to Committee on Public Health and Welfare
- Feb 19, 2026 | Senate
- Withdrawn from Calendar; Referred to Committee on Ways and Means
- Feb 18, 2026 | Senate
- Committee Report recommending bill be passed by Committee on Public Health and Welfare
- Feb 16, 2026 | Senate
- Hearing: Monday, February 16, 2026, 8:30 AM Room 142-S
- Feb 12, 2026 | Senate
- Hearing: Thursday, February 12, 2026, 8:30 AM Room 142-S
- Feb 10, 2026 | Senate
- Withdrawn from Committee on Federal and State Affairs; Referred to Committee on Public Health and Welfare
- Feb 09, 2026 | Senate
- Referred to Committee on Federal and State Affairs
- Feb 06, 2026 | Senate
- Introduced
Documents
- As introduced - Supplementary Note
- As introduced - Fiscal Note
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Minutes
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Sara Hortenstine, Executive Director Kansas Children's Death Review Board, Kansas Office of the Attorney General (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Patrick Porubsky, Laboratory Operations Manager & Forensic Chemist, Kansas Bureau of Investigation (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Bob Stuart, Executive Officer, Kansas Bureau of Investigation (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Ryan Boshears, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Misty Brown, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Aaron Estabrook, Business Owner, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Katie Patterson, Stand Up for Kansas (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Aaron Estabrook, Small Business Owner, Kansas Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Jennifer Gillis, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Max Haddow, Senior Fellow of Public Policy, American Kratom Association (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Eric Kueser, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Andrew Kulpa, Botanicals for Better Health & Wellness (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Matthew Lowe, Global Kratom Coalition (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Nick Reinecker, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Inga Selders, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Jeff Smith, PhD, National Policy Director, Holistic Alternative Recovery Trust (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Jason Todack, Small Business Owner (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Melody Woolf, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by David J. Kuntz, PhD, F-ABFT, Executive Director of Analytical toxicology, Clinical Reference Laboratory (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Robert Thompson, CEO, Clinical Reference Laboratory (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Kelly Gray, Owner Nature's Gifts, Private Citizen (Oral Opponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Senator Jeff Klemp, Kansas Senate (Oral Proponent)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Jenna Moyer, Assistant Revisor, Kansas Office of Revisor of Statutes (Bill Brief)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Written Proponents A - Z, Various (SB497 Written Proponents)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Written Opponents, Various (SB497 - Written Opponents)
- Senate Committee on Public Health and Welfare, Mon, Feb 16, 2026: Testimony by Written Opponents A - Z, Various (Written Only Opponents SB497)
- Committee Report recommending bill be passed by Committee on Public Health and Welfare
